Skip to Content

Join the 'Multiple Myeloma' group to help and get support from people like you.

Multiple Myeloma Support Group

Related terms: Cancer - Malignant Plasmacytoma, Cancer - Multiple Myeloma, Cancer - Plasma Cell Dyscrasia, Cancer - Plasma Cell Myeloma, Malignant Plasmacytoma, Myeloma - Multiple, Plasma Cell Dyscrasia, Plasma Cell Myeloma, Plasmacytoma of Bone

Summary

Our support group for Multiple Myeloma has 31 questions and 41 members. Updated 24 Sep 2017.

Popular Questions

Dexamethasone weight gain?

Posted 28 Nov 2012 1 answer

Confused over blood work results - any suggestions?

Posted 4 Aug 2010 7 answers

Is financial assistance available for Revlimid?

Posted 2 Mar 2012 2 answers

Acute Myeloid Leukemia - Multiple myeloma & aml?

Posted 6 Feb 2014 1 answer

Will Hizentra aggravate RA?

Posted 28 Feb 2013 1 answer

View more questions...

Further Information

Related Condition Support Groups

Osteolytic Bone Lesions of Multiple Myeloma, Myeloproliferative Disorders

Related Drug Support Groups

dexamethasone, Revlimid, Decadron, Cytoxan, cyclophosphamide, thalidomide, carfilzomib, Velcade, Pomalyst, view more... doxorubicin, vincristine, Adriamycin, Kyprolis, Adrenocot LA, Thalomid, Adrenocot, Neosar, Ninlaro, pomalidomide, melphalan, Dexone, Darzalex, Oncovin, Baycadron, Adriamycin PFS, Adriamycin RDF, Mozobil, Dexamethasone Intensol, Dexpak Taperpak, bortezomib, Dalalone, Dalalone DP, Dalalone LA, Decaject, Decaject LA, Medidex, Zema Pak, Farydak, Empliciti, Evomela, Zonacort, Medidex LA, Solurex, Dexacorten, Vincasar PFS, doxorubicin liposomal, lenalidomide, plerixafor, panobinostat, daratumumab, ixazomib, elotuzumab, BiCNU, Gliadel, Alkeran, Doxil, Primethasone, Cytoxan Lyophilized, Hexadrol, Decadron-LA, Solurex LA, Dexacen-4, carmustine, De-Sone LA, Dexacort-LA, Dexasone, Dexasone LA, Dexone LA, LoCort

Popular Drugs for Multiple Myeloma

Related Condition Guides

Search this Group

Latest News

Janssen Announces Darzalex (daratumumab) U.S. FDA Approval for Newly Diagnosed Patients with Multiple Myeloma who are Transplant Ineligible

HORSHAM, PA, May 7, 2018 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved Darzalex (daratumumab) in ...

Read more news...

Latest Questions

View more questions...

Top Group Members

kathyhan...
599 total answers
suzanne66
11,323 total answers
smileyha...
1,617 total answers
Chaman B...
56 total answers
rfcarter
2 total answers
Marvell
14,356 total answers

View all members...

Ask a Question